Legend Biotech has managed to remove GenScript Biotech as its majority shareholder, just as the former parent’s Chinese background falls under a U.S. biosecurity microscope. After a financial maneuver ...
GenScript’s cell therapy revenue grew by 143.7% last year as a CAR-T cell therapy developed by its Legend Biotech subsidiary gained traction. Legend Biotech continues to invest in R&D to expand the ...
GenScript ensures that suppliers adhere to PSCI's core principles regarding environment, ethics, human rights, health and safety, and management systems. By incorporating PSCI requirements into its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results